BOT 4.00% 7.2¢ botanix pharmaceuticals ltd

Looking Forward to a GREAT 2020, page-8

  1. 2,372 Posts.
    lightbulb Created with Sketch. 118
    In August 2019, Botanix completed a A$40m US-led institutional placement. The funds from the
    placement enables Botanix to execute its key clinical development programmes and accelerate its
    broader commercialisation strategy. The Company is also expecting to receive approximately A$7m
    in R&D tax incentive in 4Q CY2019. Botanix is now fully funded to progress the development of its
    rosacea and antimicrobial programs into the clinic and undertake supportive studies required prior to
    commencement of Phase 3 studies for BTX 1503.
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Mkt cap ! $72.98M
Open High Low Value Volume
7.2¢ 7.4¢ 7.2¢ $32.24K 446.1K

Buyers (Bids)

No. Vol. Price($)
5 411806 7.2¢

Sellers (Offers)

Price($) Vol. No.
7.4¢ 34759 3
View Market Depth
Last trade - 11.47am 19/05/2021 (20 minute delay) ?
-0.003 ( 1.37 %)
Open High Low Volume
7.2¢ 7.4¢ 7.2¢ 115420
Last updated 12.20pm 19/05/2021 (live) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.